ARCHIVES

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

This article is from The Cancer Letter archive.

Vol. 31 No. 22 | June 3, 2005

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Would Give Clearer Picture of C225 Role

March 8, 2002

In Brief: Selection Of NCI Director Extended By Month; Fisher Named NSABP Scientific Director

March 17, 1995

Most Comprehensive Centers Getting Core Grants Renewed

July 27, 1990

ASCO Study Predicts Shortage of Oncologists.

March 23, 2007

Centers Subcommittee Kills Guidelines Proposal, Suggest Formula Ceiling On Core Grants

January 6, 1978

Finasteride For Prostate Cancer Prevention Causes Little Or No Sexual Dysfunction

August 31, 2007